MERUS N V's ticker is MRUS and the CUSIP is N5749R100. A total of 113 filers reported holding MERUS N V in Q3 2023. The put-call ratio across all filers is 2.34 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,497,124 | -8.4% | 2,735,247 | +2.2% | 0.01% | 0.0% |
| Q2 2023 | $70,435,699 | +22.0% | 2,675,112 | -14.7% | 0.01% | +18.2% |
| Q1 2023 | $57,725,308 | +1.1% | 3,137,245 | -15.0% | 0.01% | 0.0% |
| Q4 2022 | $57,089,746 | +47.1% | 3,690,352 | +90.5% | 0.01% | +37.5% |
| Q3 2022 | $38,806,000 | -3.1% | 1,937,388 | +9.5% | 0.01% | 0.0% |
| Q2 2022 | $40,055,000 | -48.8% | 1,769,195 | -40.2% | 0.01% | -38.5% |
| Q1 2022 | $78,217,000 | -22.0% | 2,958,272 | -6.2% | 0.01% | -18.8% |
| Q4 2021 | $100,313,000 | -9.0% | 3,154,551 | -37.0% | 0.02% | -15.8% |
| Q3 2021 | $110,201,000 | +145.3% | 5,009,204 | +134.9% | 0.02% | +171.4% |
| Q2 2021 | $44,926,000 | +17.8% | 2,132,233 | +16.8% | 0.01% | 0.0% |
| Q1 2021 | $38,144,000 | +78.0% | 1,825,903 | +49.3% | 0.01% | +75.0% |
| Q4 2020 | $21,434,000 | +140.1% | 1,222,718 | +64.4% | 0.00% | +100.0% |
| Q3 2020 | $8,926,000 | -26.4% | 743,791 | -1.3% | 0.00% | -33.3% |
| Q2 2020 | $12,121,000 | +18.8% | 753,304 | -10.7% | 0.00% | 0.0% |
| Q1 2020 | $10,206,000 | -20.6% | 843,483 | -7.6% | 0.00% | 0.0% |
| Q4 2019 | $12,852,000 | -31.6% | 912,758 | -13.5% | 0.00% | -25.0% |
| Q3 2019 | $18,794,000 | +17.7% | 1,054,697 | -3.2% | 0.00% | 0.0% |
| Q2 2019 | $15,962,000 | -5.3% | 1,089,554 | -4.5% | 0.00% | 0.0% |
| Q1 2019 | $16,849,000 | +6.5% | 1,140,795 | +1.0% | 0.00% | 0.0% |
| Q4 2018 | $15,815,000 | -39.6% | 1,129,635 | -14.8% | 0.00% | -33.3% |
| Q3 2018 | $26,163,000 | -16.6% | 1,325,404 | -3.9% | 0.01% | -14.3% |
| Q2 2018 | $31,379,000 | +18.6% | 1,378,693 | -3.4% | 0.01% | +16.7% |
| Q1 2018 | $26,457,000 | +15.6% | 1,427,801 | +20.8% | 0.01% | +20.0% |
| Q4 2017 | $22,882,000 | +2.6% | 1,181,946 | +5.3% | 0.01% | 0.0% |
| Q3 2017 | $22,304,000 | +15.7% | 1,122,468 | -7.7% | 0.01% | 0.0% |
| Q2 2017 | $19,280,000 | -35.4% | 1,216,343 | -0.6% | 0.01% | -28.6% |
| Q1 2017 | $29,841,000 | – | 1,223,976 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 1,600,000 | $33,712,000 | 6.04% |
| BVF INC/IL | 7,285,071 | $153,496,000 | 5.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 320,815 | $6,760,000 | 3.02% |
| Burrage Capital Management LLC | 130,683 | $2,753,000 | 2.76% |
| MPM BioImpact LLC | 700,879 | $14,768,000 | 2.43% |
| Boxer Capital, LLC | 1,900,000 | $40,033,000 | 1.41% |
| Octagon Capital Advisors LP | 206,927 | $4,360,000 | 0.90% |
| DAFNA Capital Management LLC | 157,841 | $3,326,000 | 0.70% |
| Ghost Tree Capital, LLC | 75,000 | $1,580,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 286,506 | $6,037,000 | 0.41% |